MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.
Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.
Accurate targeting of cortical regions in rodent models is critical for a variety of neuroscientific applications, including electrophysiological recordings, viral vector delivery, and tracer injections.
We are pleased to introduce our new CRO In Vivo Imaging and Analytical Services, designed to support academic and preclinical researchers in the fields of
Copyright © 2024 · MediLumine, Inc · All Rights Reserved
